Avricore Health (AVCRF) Gains from Investment Securities (2010 - 2020)
Avricore Health (AVCRF) posted quarterly Gains from Investment Securities of -$4984.3 for Q4 2020, down 32.81% quarter-over-quarter from -$3752.9 in Q3 2020.
Avricore Health (AVCRF) Gains from Investment Securities (2010 - 2020) Analysis & Trends
Avricore Health (AVCRF) has reported Gains from Investment Securities for 4 consecutive years, with -$4984.3 the latest figure, recorded in Q4 2020.
- In Q4 2020, Gains from Investment Securities changed N/A year-over-year to -$4984.3; the TTM figure through Dec 2020 stood at $151398.1 (changed N/A YoY), while the FY2024 annual figure was -$7304.0, changed N/A from the prior year.
- Gains from Investment Securities retreated to -$4984.3 in Q4 2020 per AVCRF's latest filing, from -$3752.9 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $169252.3 in Q4 2018 and bottomed at -$4984.3 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn |
| 10 | Avricore Health | 3.04 Mn | 3.01 Mn | -6,202.70 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | -4,984.32 |
| Dec 31, 2020 | -4,984.32 |
| Sep 30, 2020 | -3,752.87 |
| Sep 30, 2020 | -3,752.87 |
| Dec 31, 2018 | 169,252.26 |
| Dec 31, 2018 | 169,252.26 |
| Jun 30, 2011 | -9,116.96 |
| Jun 30, 2011 | -9,116.96 |
| Sep 30, 2010 | 32,165.01 |
| Sep 30, 2010 | 32,165.01 |